Nucleate Boston Announces Exclusive Legal Partnership with Mintz for Activator Program

3 min readFeb 20, 2023


Nucleate Boston, a nonprofit organization dedicated to empowering the next generation of biotech leaders, announces its partnership with Mintz, a leading law firm in the biotechnology sphere. Mintz will provide exclusive legal support to Nucleate Boston’s 2023 Activator program, which facilitates early-stage company formation in the life sciences.

As noted by Mintz Life Sciences and Venture Capital and Emerging Companies Member Josh Fox, “Mintz is a leading law firm in the biotech space, advising companies on corporate transactions, intellectual property, regulatory matters and litigation, so this partnership makes perfect sense for us as a firm.” In describing the synergies between his practice and Nucleate, Josh commented, “My practice focuses on representing entrepreneurs and start-ups in the life sciences industry, so it’s a great match for me to be collaborating with Nucleate. In addition, I am excited to be working with the start-ups that are part of Nucleate and look forward to helping the entrepreneurs and founders that are part of the program.”

The Activator is Nucleate’s flagship educational program that empowers academic trainees to translate their groundbreaking science into successful companies. With over 50 early-stage venture teams supported since its inception in 2019, Activator provides participants with an unparalleled network, educational workshops, and legal support to facilitate entrepreneurship education and team formation.

“We are thrilled to partner with Mintz and have their support as our regional legal partner,” said Oliver Dodd, Co-Founder and Co-President of Nucleate. “With their expertise in advising life science companies, Mintz is the perfect fit to help our Activator program participants achieve their goals.”

“We are grateful for Mintz’s support of our Activator program and their commitment to the success of our participants,” said Emma Bortz, Nucleate Boston Director of Sponsorships. “With Mintz’s legal expertise and Nucleate’s educational resources, our Activator teams will have the tools they need to bring their innovative ideas to life.”

The 2023 Activator Program began this January and will support over 100 new ventures worldwide with 17 teams in the Boston Chapter. Activator teams will participate in hands-on workshops and receive mentorship from industry experts throughout the program, culminating in a final pitch showcase.

About Mintz

Mintz, a leading life sciences law firm, represents therapeutics, vaccine, medical device and systems, research tools and diagnostics companies, as well as investment banks, venture capital firms and other investors. Our work for these clients encompasses transactional, health care regulatory, intellectual property, litigation, employment, real estate and other matters. We are embedded in the global life sciences ecosystem and provide industry leaders with practical solutions to business-critical challenges, helping them achieve their strategic and business goals.

· $22 billion+ in transactions handled in 2021 for industry clients, including public offerings, joint ventures, licensing and complex collaborations, mergers and acquisitions, divestitures, distribution deals, and private financings

· Advise on the complete spectrum of FDA regulations, from clinical trials through product launch and beyond, including product approvals, labeling, and supply and distribution agreements

· Prosecute patents to issuance (more than 30 patent team members have biology or chemistry PhDs), navigate trademarks through the USPTO and health regulatory bodies, and defend patent, trade secret and trademark rights in trial courts and at the USPTO

· Successful track record of helping life sciences clients avoid — and when necessary resolve — securities class actions, governmental investigations, and disputes with collaboration/licensing partners

To learn more about our life sciences practice, please visit

About Nucleate

Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 18 geographic regions and participation from over 120 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit for more information, and email if you want to get involved with our programming.

About the Activator Program

Nucleate’s flagship educational program, Activator, facilitates the formation of new life science companies solving pressing biomedical or ecological challenges. Unlike traditional accelerators, Activator is an equity-free, fee-free, hands-on entrepreneurship program that stimulates regional innovation and builds a global community of biotech entrepreneurs. Empowering academic trainees to translate their groundbreaking science into successful companies, Activator facilitates entrepreneurial education through team formation, mentorship and expert support, rigorous workshop series, and a final pitch showcase.